We found ERBB2 gene amplification in one patient affected by metastatic UPS of the lower limb, and one gain of function point mutation resulting in the amino acid substitution R678W in a patient affected by metastatic MPNST of the lower limb. This evidence concerns the gene ERBB2 and malignant peripheral nerve sheath tumor.